Literature DB >> 25851318

Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure.

Jacqueline Saw1, Peter Fahmy2, Peggy DeJong2, Mathieu Lempereur2, Ryan Spencer2, Michael Tsang2, Kenneth Gin2, John Jue2, John Mayo2, Patrick McLaughlin2, Savvas Nicolaou2.   

Abstract

AIMS: Left atrial appendage (LAA) device imaging after endovascular closure is important to assess for device thrombus, residual leak, positioning, surrounding structures, and pericardial effusion. Cardiac CT angiography (CCTA) is well suited to assess these non-invasively. METHODS AND
RESULTS: We report our consecutive series of non-valvular atrial fibrillation patients who underwent CCTA post-LAA closure with Amplatzer Cardiac Plug (ACP), Amulet (second generation ACP), or WATCHMAN devices. Patients underwent CCTA typically 1-6 months post-implantation. Prospective cardiac-gated CCTA was performed with Toshiba 320-detector or Siemens 2nd generation 128-slice dual-source scanners, and images interpreted with VitreaWorkstation™. GFR <30 mL/min/1.73 m(2) was an exclusion. We assessed for device thrombus, residual LAA leak, device embolization, position, pericardial effusion, optimal implantation, and device lobe dimensions. Forty-five patients underwent CCTA at median 97 days post-LAA closure (18 ACP, 9 Amulet, 18 WATCHMAN). Average age was 75.5 ± 8.9 years, mean CHADS2 score 3.1 ± 1.3, and CHADS-VASc score 4.9 ± 1.6. All had contraindications to oral anticoagulation. Post-procedure, 41 (91.1%) were discharged on DAPT. There was one device embolization (ACP, successfully retrieved percutaneously) and one thrombus (WATCHMAN, resolved with 3 months of warfarin). There were two pericardial effusions, both pre-existing and not requiring intervention. Residual leak (patency) was seen in 28/44 (63.6%), and the mechanisms of leak were readily identified by CCTA (off-axis device, gaps at orifice, or fabric leak). Mean follow-up was 1.2 ± 1.1year, with no death, stroke, or systemic embolism.
CONCLUSION: CCTA appears to be a feasible alternative to transoesophageal echocardiography for post-LAA device surveillance to evaluate for device thrombus, residual leak, embolization, position, and pericardial effusion. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Amplatzer cardiac plug; Amulet; WATCHMAN; cardiac CTA; left atrial appendage closure

Mesh:

Substances:

Year:  2015        PMID: 25851318      PMCID: PMC4609159          DOI: 10.1093/ehjci/jev067

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  16 in total

1.  Cardiac computed tomography follow-up of left atrial appendage exclusion using the Amplatzer Cardiac Plug device.

Authors:  Rohan S Poulter; Jonathon Tang; John Jue; Reda Ibrahim; Savvas Nicolaou; John Mayo; Jacqueline Saw
Journal:  Can J Cardiol       Date:  2011-11-29       Impact factor: 5.223

2.  Left atrial appendage obliteration: mechanisms of healing and intracardiac integration.

Authors:  Robert S Schwartz; David R Holmes; Robert A Van Tassel; Robert Hauser; Timothy D Henry; Michael Mooney; Ray Matthews; Shephal Doshi; Russell M Jones; Renu Virmani
Journal:  JACC Cardiovasc Interv       Date:  2010-08       Impact factor: 11.195

3.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

4.  The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.

Authors:  Juan F Viles-Gonzalez; Saibal Kar; Pamela Douglas; Srinivas Dukkipati; Ted Feldman; Rodney Horton; David Holmes; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2012-03-06       Impact factor: 24.094

5.  Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device.

Authors:  Milosz Jaguszewski; Costantina Manes; Gilbert Puippe; Sacha Salzberg; Maja Müller; Volkmar Falk; Thomas Lüscher; Andreas Luft; Hatem Alkadhi; Ulf Landmesser
Journal:  Catheter Cardiovasc Interv       Date:  2014-10-04       Impact factor: 2.692

6.  Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.

Authors:  A S Go; E M Hylek; L H Borowsky; K A Phillips; J V Selby; D E Singer
Journal:  Ann Intern Med       Date:  1999-12-21       Impact factor: 25.391

Review 7.  Percutaneous left atrial appendage closure: procedural techniques and outcomes.

Authors:  Jacqueline Saw; Mathieu Lempereur
Journal:  JACC Cardiovasc Interv       Date:  2014-11-17       Impact factor: 11.195

8.  Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug.

Authors:  Apostolos Tzikas; Samera Shakir; Sameer Gafoor; Heyder Omran; Sergio Berti; Gennaro Santoro; Joelle Kefer; Ulf Landmesser; Jens Erik Nielsen-Kudsk; Ignacio Cruz-Gonzalez; Horst Sievert; Tobias Tichelbäcker; Prapa Kanagaratnam; Fabian Nietlispach; Adel Aminian; Friederike Kasch; Xavier Freixa; Paolo Danna; Marco Rezzaghi; Paul Vermeersch; Friederike Stock; Miroslava Stolcova; Marco Costa; Reda Ibrahim; Wolfgang Schillinger; Bernhard Meier; Jai-Wun Park
Journal:  EuroIntervention       Date:  2016-02       Impact factor: 6.534

9.  Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the Amplatzer cardiac plug.

Authors:  José R López-Mínguez; Javier Eldoayen-Gragera; Reyes González-Fernández; Concepción Fernández-Vegas; María E Fuentes-Cañamero; Victoria Millán-Nuñez; Juan M Nogales-Asensio; Ana Martínez-Naharro; Sara Sánchez-Giralt; Manuel Doblado-Calatrava; Antonio Merchán-Herrera
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2012-08-29

10.  Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy.

Authors:  Marina Urena; Josep Rodés-Cabau; Xavier Freixa; Jacqueline Saw; John G Webb; Mélanie Freeman; Eric Horlick; Mark Osten; Albert Chan; Jean-Francois Marquis; Jean Champagne; Réda Ibrahim
Journal:  J Am Coll Cardiol       Date:  2013-05-09       Impact factor: 24.094

View more
  19 in total

1.  Cardiac CT Angiography (CCTA) predicts left atrial appendage occluder device size and procedure outcome.

Authors:  Orly Goitein; Noam Fink; Ilan Hay; Elio Di Segni; Victor Guetta; David Goitein; Yafim Brodov; Eli Konen; Michael Glikson
Journal:  Int J Cardiovasc Imaging       Date:  2017-01-09       Impact factor: 2.357

2.  Watchman outcomes comparing post-implantation anticoagulation with warfarin versus direct oral anticoagulants.

Authors:  Ethan Fry; Harini Bollempali; Keith Suarez; Javier Banchs; Jeffrey Michel
Journal:  J Interv Card Electrophysiol       Date:  2020-06-05       Impact factor: 1.900

Review 3.  Computed tomography measurement for left atrial appendage closure.

Authors:  Masahiko Asami
Journal:  Cardiovasc Interv Ther       Date:  2022-03-20

4.  Percutaneous Left Atrial Appendage Closure Using an Occluder Device: A Single Center Experience.

Authors:  Isaiah C Lugtu; Wen-Han Cheng; Shih-Lin Chang; Shin-Huei Liu; Li-Wei Lo; Shih-Ann Chen
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

5.  Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging-part II.

Authors:  Gianluca Pontone; Alexia Rossi; Marco Guglielmo; Marc R Dweck; Oliver Gaemperli; Koen Nieman; Francesca Pugliese; Pal Maurovich-Horvat; Alessia Gimelli; Bernard Cosyns; Stephan Achenbach
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-03-22       Impact factor: 9.130

6.  Computed Tomography for Structural Heart Disease and Interventions.

Authors:  Pascal Thériault-Lauzier; Marco Spaziano; Beatriz Vaquerizo; Jean Buithieu; Giuseppe Martucci; Nicolo Piazza
Journal:  Interv Cardiol       Date:  2015-09

7.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

8.  Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure.

Authors:  Roberto Galea; Federico De Marco; Adel Aminian; Nicolas Meneveau; Frederic Anselme; Christoph Gräni; Adrian T Huber; Emmanuel Teiger; Xavier Iriart; Marco Angelillis; Nicolas Brugger; Alessandro Spirito; Noé Corpataux; Anna Franzone; Pascal Vranckx; Urs Fischer; Giovanni Pedrazzini; Francesco Bedogni; Stephan Windecker; Lorenz Räber; Marco Valgimigli
Journal:  J Cardiovasc Transl Res       Date:  2021-04-21       Impact factor: 4.132

9.  Reduced plasma level of basic fibroblast growth factor is associated with incomplete device endothelialization at six months following left atrial appendage closure.

Authors:  Jing Xu; Xin Gong; Chuanzhi Chen; Jun Xing; Qi Wang; Weifeng Shen; Qi Zhang
Journal:  BMC Cardiovasc Disord       Date:  2021-05-16       Impact factor: 2.298

Review 10.  Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding.

Authors:  Giovanni Cimmino; Francesco S Loffredo; Emanuele Gallinoro; Dario Prozzo; Dario Fabiani; Luigi Cante; Gemma Salerno; Maurizio Cappelli Bigazzi; Paolo Golino
Journal:  Medicina (Kaunas)       Date:  2021-05-03       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.